These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19535262)

  • 1. New mechanisms for PRLr action in breast cancer.
    Clevenger CV; Gadd SL; Zheng J
    Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
    Lim JH; Kim TY; Kim WH; Park JW
    Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
    Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV
    Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone.
    van Agthoven J; Zhang C; Tallet E; Raynal B; Hoos S; Baron B; England P; Goffin V; Broutin I
    J Mol Biol; 2010 Nov; 404(1):112-26. PubMed ID: 20875426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
    Langenheim JF; Chen WY
    J Recept Signal Transduct Res; 2009; 29(2):107-12. PubMed ID: 19519175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.
    Shao R; Nutu M; Weijdegård B; Egecioglu E; Fernandez-Rodriguez J; Tallet E; Goffin V; Ling C; Billig H
    Biol Reprod; 2008 Oct; 79(4):748-57. PubMed ID: 18596217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer.
    Damiano JS; Wasserman E
    Clin Cancer Res; 2013 Apr; 19(7):1644-50. PubMed ID: 23515410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and the prolactin receptor: new targets of an old hormone.
    Harris J; Stanford PM; Oakes SR; Ormandy CJ
    Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and functional interaction between cyclophilin A and prolactin receptor.
    Syed F; Rycyzyn MA; Westgate L; Clevenger CV
    Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
    Kline JB; Rycyzyn MA; Clevenger CV
    Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
    Liu Y; Zhang Y; Jiang J; Lobie PE; Paulmurugan R; Langenheim JF; Chen WY; Zinn KR; Frank SJ
    Mol Endocrinol; 2016 May; 30(5):504-17. PubMed ID: 27003442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prolactin and its receptor in human breast carcinoma.
    Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
    Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.